AUPH Aurinia Pharmaceuticals Inc.
Nasdaq · SEC CIK 1600620 · EDGAR
- Bought, last 12 months
- $25.14M 2 purchases by 1 insiders
- Sold, last 12 months
- $546.4K 2 sales by 1 insiders
- Filings on record
- 132 since 2021-07-29, latest 2026-09-11 16:26
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| TANG KEVIN | Dir | $25.14M | — |
| Robertson Stephen P. | EVP, GC | — | $546.4K |
| Cole Ryan | COO | — | — |
| Keenan Greg | SVP, Chief Medical Off | — | — |
| Hearne Michael S | CFO | — | — |
| Miller Joseph M | CFO | — | — |
| Donley Matthew Maxwell | COO | — | — |
| Bailey Jeffrey Allen | Dir | — | — |
| Johnson Craig A | Dir | — | — |
| Greenleaf Peter | CEO, Dir | — | — |
Transactions 158
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 16:26 | 2026-09-10 | AUPH | Robertson Stephen P. | CLO | S - Sale | $15.95 | -11.9K | 588.8K | -2% | -$190.4K | |
| 2026-08-25 21:29 | 2026-08-21 | AUPH | Robertson Stephen P. | CLO | S - Sale | $16.97 | -21.0K | 600.8K | -3% | -$355.9K | |
| DMI | 2026-06-02 21:54 | 2026-05-29+ | AUPH | TANG KEVIN | CEO, Dir, 10% | P - Purchase | $15.29 | +814.6K | 13.04M | +7% | +$12.46M |
| 2026-05-20 17:05 | 2026-05-18 | AUPH | Robertson Stephen P. | CLO | A - Grant | $0.00 | +115.5K | 621.4K | +23% | $0 | |
| D | 2026-05-20 17:04 | 2026-05-18 | AUPH | Hearne Michael S | CFO | A - Grant | $0.00 | +116.1K | 116.1K | New | $0 |
| D | 2026-05-20 17:03 | 2026-05-18 | AUPH | Cole Ryan | COO | A - Grant | $0.00 | +116.1K | 116.1K | New | $0 |
| 2026-03-10 | 2026-03-06 | AUPH | Keenan Greg | SVP, Chief Medical Off | F - Tax | $14.32 | -8,069 | 154.4K | -5% | -$115.5K | |
| D | 2026-03-03 | 2026-03-02 | AUPH | Donley Matthew Maxwell | COO | F - Tax | $14.21 | -40.8K | 680.3K | -6% | -$579.2K |
| D | 2026-03-03 | 2026-02-27 | AUPH | Donley Matthew Maxwell | COO | A - Grant | $0.00 | +58.2K | 721.1K | +9% | $0 |
| D | 2026-03-03 | 2026-02-27 | AUPH | Keenan Greg | SVP, Chief Medical Off | A - Grant | $0.00 | +40.6K | 162.5K | +33% | $0 |
| MI | 2026-03-03 | 2026-02-27+ | AUPH | TANG KEVIN | Dir | P - Purchase | $14.10 | +900.0K | 11.63M | +8% | +$12.69M |
| D | 2026-03-03 | 2026-03-02 | AUPH | Greenleaf Peter | CEO, Dir | F - Tax | $14.21 | -100.9K | 1.84M | -5% | -$1.43M |
| D | 2026-03-03 | 2026-02-27 | AUPH | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +196.4K | 1.94M | +11% | $0 |
| D | 2026-03-03 | 2026-03-02 | AUPH | Miller Joseph M | CFO | F - Tax | $14.21 | -37.5K | 576.4K | -6% | -$533.0K |
| D | 2026-03-03 | 2026-02-27 | AUPH | Miller Joseph M | CFO | A - Grant | $0.00 | +57.2K | 613.9K | +10% | $0 |
| D | 2026-03-03 | 2026-03-02 | AUPH | Robertson Stephen P. | EVP, GC | F - Tax | $14.21 | -36.5K | 505.9K | -7% | -$519.0K |
| D | 2026-03-03 | 2026-02-27 | AUPH | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +59.1K | 542.4K | +12% | $0 |
| 2026-02-23 | 2026-02-20 | AUPH | Greenleaf Peter | CEO, Dir | F - Tax | $14.40 | -100.2K | 1.74M | -5% | -$1.44M | |
| 2026-02-23 | 2026-02-20 | AUPH | Donley Matthew Maxwell | COO | F - Tax | $14.40 | -32.9K | 662.9K | -5% | -$473.8K | |
| 2026-02-23 | 2026-02-20 | AUPH | Miller Joseph M | CFO | F - Tax | $14.40 | -32.4K | 556.7K | -6% | -$466.9K | |
| 2026-02-23 | 2026-02-20 | AUPH | Robertson Stephen P. | EVP, GC | F - Tax | $14.40 | -34.6K | 483.3K | -7% | -$498.8K | |
| 2026-02-03 | 2026-02-02 | AUPH | Keenan Greg | SVP, Chief Medical Off | F - Tax | $14.53 | -11.6K | 121.9K | -9% | -$167.9K | |
| 2026-01-05 | 2026-01-02 | AUPH | Donley Matthew Maxwell | COO | F - Tax | $15.95 | -42.8K | 695.8K | -6% | -$682.5K | |
| 2026-01-05 | 2026-01-02 | AUPH | Donley Matthew Maxwell | COO | A - Grant | $0.00 | +54.2K | 734.6K | +8% | $0 | |
| 2026-01-05 | 2026-01-02 | AUPH | Miller Joseph M | CFO | A - Grant | $0.00 | +49.0K | 626.4K | +8% | $0 | |
| 2026-01-05 | 2026-01-02 | AUPH | Miller Joseph M | CFO | F - Tax | $15.95 | -40.2K | 589.1K | -6% | -$640.6K | |
| 2026-01-05 | 2026-01-02 | AUPH | Greenleaf Peter | CEO, Dir | F - Tax | $15.95 | -113.2K | 1.85M | -6% | -$1.81M | |
| 2026-01-05 | 2026-01-02 | AUPH | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +165.4K | 1.95M | +9% | $0 | |
| 2026-01-05 | 2026-01-02 | AUPH | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +48.6K | 557.4K | +10% | $0 | |
| 2026-01-05 | 2026-01-02 | AUPH | Robertson Stephen P. | EVP, GC | F - Tax | $15.95 | -40.4K | 517.9K | -7% | -$644.1K | |
| 2025-11-24 | 2025-11-21 | AUPH | Johnson Craig A | Dir | F - Tax | $15.68 | -6,039 | 14.6K | -29% | -$94.7K | |
| 2025-11-24 | 2025-11-21 | AUPH | Bailey Jeffrey Allen | Dir | F - Tax | $15.68 | -2,716 | 22.8K | -11% | -$42.6K | |
| MI | 2025-08-05 | 2025-08-01+ | AUPH | TANG KEVIN | Dir | P - Purchase | $10.45 | +1.30M | 11.13M | +13% | +$13.59M |
| 2025-08-05 | 2025-08-01 | AUPH | Keenan Greg | Chief Medical Off | S - Sale | $10.50 | -20.0K | 133.5K | -13% | -$210.0K | |
| 2025-03-07 | 2025-03-07 | AUPH | Keenan Greg | Chief Medical Off | S - Sale | $8.23 | -8,305 | 153.5K | -5% | -$68.4K | |
| DM | 2025-03-04 | 2025-03-03+ | AUPH | Greenleaf Peter | CEO, Dir | S - Sale | $7.96 | -360.5K | 1.79M | -17% | -$2.87M |
| DM | 2025-03-04 | 2025-02-28+ | AUPH | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +624.4K | 1.82M | +52% | $0 |
| DM | 2025-03-04 | 2025-03-03+ | AUPH | Miller Joseph M | CFO | S - Sale | $7.96 | -118.0K | 633.5K | -16% | -$939.6K |
| DM | 2025-03-04 | 2025-02-28+ | AUPH | Miller Joseph M | CFO | A - Grant | $0.00 | +196.2K | 695.4K | +39% | $0 |
| MI | 2025-03-04 | 2025-02-28+ | AUPH | TANG KEVIN | Dir | P - Purchase | $7.95 | +1.60M | 9.28M | +21% | +$12.71M |
| DM | 2025-03-04 | 2025-03-03+ | AUPH | Robertson Stephen P. | EVP, GC | S - Sale | $7.96 | -122.5K | 566.9K | -18% | -$975.2K |
| DM | 2025-03-04 | 2025-02-28+ | AUPH | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +186.5K | 529.3K | +54% | $0 |
| D | 2025-03-04 | 2025-03-03 | AUPH | Keenan Greg | Chief Medical Off | S - Sale | $8.00 | -12.2K | 161.8K | -7% | -$97.9K |
| D | 2025-03-04 | 2025-02-28 | AUPH | Keenan Greg | Chief Medical Off | A - Grant | $0.00 | +62.6K | 174.0K | +56% | $0 |
| DM | 2025-03-04 | 2025-03-03+ | AUPH | Donley Matthew Maxwell | COO | S - Sale | $7.96 | -124.9K | 680.5K | -16% | -$994.4K |
| DM | 2025-03-04 | 2025-02-28+ | AUPH | Donley Matthew Maxwell | COO | A - Grant | $0.00 | +218.3K | 669.8K | +48% | $0 |
| MI | 2024-12-09 | 2024-12-05+ | AUPH | TANG KEVIN | Dir | P - Purchase | $9.02 | +1.20M | 8.43M | +17% | +$10.82M |
| D | 2024-11-25 | 2024-11-21 | AUPH | Jayne David R.W. | Dir | A - Grant | $0.00 | +12.1K | 56.5K | +27% | $0 |
| D | 2024-11-25 | 2024-11-21 | AUPH | Smith Karen L. | Dir | A - Grant | $0.00 | +12.1K | 24.8K | +96% | $0 |
| D | 2024-11-25 | 2024-11-21 | AUPH | Leversage Jill | Dir | A - Grant | $0.00 | +12.1K | 25.1K | +94% | $0 |
| D | 2024-11-25 | 2024-11-21 | AUPH | Johnson Craig A | Dir | A - Grant | $0.00 | +20.6K | 20.6K | New | $0 |
| D | 2024-11-25 | 2024-11-21 | AUPH | Bailey Jeffrey Allen | Dir | A - Grant | $0.00 | +12.1K | 25.5K | +91% | $0 |
| D | 2024-11-12 | 2024-11-08 | AUPH | Smith Karen L. | Dir | M - OptEx | — | +17.9K | 17.9K | New | — |
| D | 2024-11-12 | 2024-11-11 | AUPH | Smith Karen L. | Dir | S - Sale+OE | $8.43 | -5,241 | 12.7K | -29% | -$44.2K |
| D | 2024-11-12 | 2024-11-08 | AUPH | Bailey Jeffrey Allen | Dir | M - OptEx | — | +17.9K | 17.9K | New | — |
| D | 2024-11-12 | 2024-11-11 | AUPH | Bailey Jeffrey Allen | Dir | S - Sale+OE | $8.43 | -4,557 | 13.4K | -25% | -$38.4K |
| 2024-08-08 | 2024-08-06 | AUPH | Habig Scott Michael | Chief Commercial Off | S - Sale | $5.31 | -18.2K | 456.3K | -4% | -$96.9K | |
| 2024-05-22 | 2024-05-21 | AUPH | MacKay-Dunn R. Hector | Dir | S - Sale | $5.74 | -5,630 | 18.6K | -23% | -$32.3K | |
| 2024-05-22 | 2024-05-21 | AUPH | Jayne David R.W. | Dir | S - Sale | $5.74 | -4,946 | 44.4K | -10% | -$28.4K | |
| 2024-05-22 | 2024-05-21 | AUPH | Balakrishnan Brinda | Dir | S - Sale | $5.74 | -520 | 17.5K | -3% | -$2,985 | |
| 2024-05-22 | 2024-05-21 | AUPH | Billen Daniel | Dir | S - Sale | $5.74 | -5,252 | 28.1K | -16% | -$30.1K | |
| 2024-05-22 | 2024-05-21 | AUPH | Leversage Jill | Dir | S - Sale | $5.74 | -5,610 | 12.9K | -30% | -$32.2K | |
| 2024-03-07 | 2024-03-06 | AUPH | Greenleaf Peter | CEO, Dir | S - Sale | $5.60 | -127.0K | 1.52M | -8% | -$711.1K | |
| 2024-03-07 | 2024-03-06 | AUPH | Robertson Stephen P. | EVP, GC | S - Sale | $5.60 | -57.7K | 443.8K | -12% | -$323.4K | |
| 2024-03-07 | 2024-03-06 | AUPH | Habig Scott Michael | Chief Commercial Off | S - Sale | $5.60 | -17.8K | 474.6K | -4% | -$99.6K | |
| 2024-03-07 | 2024-03-06 | AUPH | Donley Matthew Maxwell | EVP, Ops, Strategy | S - Sale | $5.51 | -40.7K | 584.1K | -7% | -$224.1K | |
| 2024-03-07 | 2024-03-06 | AUPH | Miller Joseph M | CFO | S - Sale | $5.60 | -34.8K | 495.9K | -7% | -$194.9K | |
| 2024-02-29 | 2024-02-27 | AUPH | Knappertz Volker | EVP, Research, Development | S - Sale | $6.10 | -4,930 | 319.1K | -2% | -$30.1K | |
| 2024-02-22 | 2024-02-20 | AUPH | Knappertz Volker | EVP, Research, Development | S - Sale | $5.48 | -25.1K | 324.1K | -7% | -$137.8K | |
| A | 2024-02-22 | 2023-03-02 | AUPH | Miller Joseph M | CFO | S - Sale | $8.78 | -11.4K | 331.1K | -3% | -$100.1K |
| 2024-02-22 | 2024-02-20 | AUPH | Donley Matthew Maxwell | EVP, Ops, Strategy | A - Grant | $0.00 | +216.7K | 624.7K | +53% | $0 | |
| A | 2024-02-22 | 2023-03-02 | AUPH | Robertson Stephen P. | EVP, GC | S - Sale | $8.78 | -19.6K | 303.1K | -6% | -$172.5K |
| 2024-02-22 | 2024-02-20 | AUPH | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +661.5K | 1.65M | +67% | $0 | |
| 2024-02-22 | 2024-02-20 | AUPH | Habig Scott Michael | Chief Commercial Off | S - Sale | $5.48 | -15.9K | 492.4K | -3% | -$87.0K | |
| 2024-02-22 | 2024-02-20 | AUPH | Habig Scott Michael | Chief Commercial Off | A - Grant | $0.00 | +195.5K | 508.2K | +63% | $0 | |
| 2024-02-22 | 2024-02-20 | AUPH | Miller Joseph M | CFO | A - Grant | $0.00 | +196.2K | 530.7K | +59% | $0 | |
| A | 2024-02-22 | 2023-03-02 | AUPH | Greenleaf Peter | CEO, Dir | S - Sale | $8.78 | -33.0K | 982.7K | -3% | -$290.2K |
| 2024-02-22 | 2024-02-20 | AUPH | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +194.2K | 501.6K | +63% | $0 | |
| D | 2023-05-23 | 2023-05-18 | AUPH | MILNE GEORGE M JR | Dir | M - OptEx | — | +8,733 | 78.7K | +12% | — |
| D | 2023-05-23 | 2023-05-19 | AUPH | Leversage Jill | Dir | A - Grant | $0.00 | +9,310 | 23.3K | +66% | $0 |
| D | 2023-05-23 | 2023-05-23 | AUPH | Leversage Jill | Dir | S - Sale+OE | $11.26 | -4,815 | 18.5K | -21% | -$54.2K |
| D | 2023-05-23 | 2023-05-18 | AUPH | Leversage Jill | Dir | M - OptEx | — | +8,733 | 14.0K | +165% | — |
| D | 2023-05-23 | 2023-05-23 | AUPH | Billen Daniel | Dir | S - Sale+OE | $11.26 | -4,650 | 33.4K | -12% | -$52.4K |
| D | 2023-05-23 | 2023-05-18 | AUPH | Billen Daniel | Dir | M - OptEx | — | +8,733 | 28.7K | +44% | — |
| D | 2023-05-23 | 2023-05-19 | AUPH | Billen Daniel | Dir | A - Grant | $0.00 | +9,310 | 38.0K | +32% | $0 |
| D | 2023-05-23 | 2023-05-19 | AUPH | MacKay-Dunn R. Hector | Dir | A - Grant | $0.00 | +9,310 | 29.0K | +47% | $0 |
| D | 2023-05-23 | 2023-05-23 | AUPH | MacKay-Dunn R. Hector | Dir | S - Sale+OE | $11.26 | -4,818 | 24.2K | -17% | -$54.3K |
| D | 2023-05-23 | 2023-05-18 | AUPH | MacKay-Dunn R. Hector | Dir | M - OptEx | — | +8,733 | 19.7K | +79% | — |
| D | 2023-05-23 | 2023-05-18 | AUPH | Hagan Joseph P | Dir | M - OptEx | — | +8,733 | 12.2K | +250% | — |
| D | 2023-05-23 | 2023-05-19 | AUPH | Hagan Joseph P | Dir | S - Sale+OE | $10.58 | -272 | 12.0K | -2% | -$2,878 |
| D | 2023-05-23 | 2023-05-19 | AUPH | Balakrishnan Brinda | Dir | A - Grant | $0.00 | +9,310 | 18.0K | +107% | $0 |
| D | 2023-05-23 | 2023-05-18 | AUPH | Balakrishnan Brinda | Dir | M - OptEx | — | +8,733 | 8,733 | New | — |
| D | 2023-05-23 | 2023-05-18 | AUPH | Jayne David R.W. | Dir | M - OptEx | — | +8,733 | 48.7K | +22% | — |
| D | 2023-05-23 | 2023-05-23 | AUPH | Jayne David R.W. | Dir | S - Sale+OE | $11.26 | -8,733 | 49.3K | -15% | -$98.3K |
| D | 2023-05-23 | 2023-05-19 | AUPH | Jayne David R.W. | Dir | A - Grant | $0.00 | +9,310 | 58.0K | +19% | $0 |
| 2023-03-06 | 2023-03-02 | AUPH | Miller Joseph M | CFO | A - Grant | — | +229.4K | 342.5K | +203% | — | |
| 2023-03-06 | 2023-03-02 | AUPH | Miller Joseph M | CFO | S - Sale | $8.94 | -11.3K | 331.2K | -3% | -$101.0K | |
| 2023-03-06 | 2023-03-02 | AUPH | Robertson Stephen P. | EVP, GC | A - Grant | — | +204.8K | 322.8K | +174% | — | |
| 2023-03-06 | 2023-03-02 | AUPH | Robertson Stephen P. | EVP, GC | S - Sale | $8.94 | -19.4K | 303.4K | -6% | -$173.5K | |
| 2023-03-06 | 2023-03-02 | AUPH | Greenleaf Peter | CEO, Dir | S - Sale | $8.94 | -32.8K | 983.0K | -3% | -$292.8K |
Purchase Sale Sale after option exercise All abbreviations